Amelioration of pancreatic fat accumulation in Japanese type 2 diabetes patients treated with sodium‐glucose cotransporter 2 inhibitors: a retrospective study

Prior reports have suggested that pancreatic fat is related to type 2 diabetes. Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors are expected to reduce ectopic fat accumulation.

[1]  I. Shimomura,et al.  Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes , 2020, BMJ open diabetes research & care.

[2]  S. Yun,et al.  Development and Validation of a Simple Index Based on Non-Enhanced CT and Clinical Factors for Prediction of Non-Alcoholic Fatty Liver Disease , 2020, Korean journal of radiology.

[3]  I. Shimomura,et al.  Pancreatic fat is related to the longitudinal decrease in the increment of C‐peptide in glucagon stimulation test in type 2 diabetes patients , 2019, Journal of diabetes investigation.

[4]  Kunihiro Suzuki,et al.  Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease , 2018, Diabetes, obesity & metabolism.

[5]  E. Blaak,et al.  Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions , 2018, Front. Nutr..

[6]  I. Shimomura,et al.  Glucose Intolerance After Pancreatectomy Was Associated With Preoperative Hemoglobin A1c, Insulin Resistance, and Histological Pancreatic Fatty Infiltration , 2018, Pancreas.

[7]  A. Mithal,et al.  Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) , 2018, Diabetes Care.

[8]  K. Shimada,et al.  Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  C. Leitão,et al.  Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies , 2017, PloS one.

[10]  H. Miyoshi,et al.  Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. , 2017, Endocrine journal.

[11]  Mariela Glandt,et al.  Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature , 2016, Gastroenterology research.

[12]  H. Miyoshi,et al.  Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. , 2016, Endocrine journal.

[13]  P. Iozzo,et al.  The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. , 2015, The Journal of clinical endocrinology and metabolism.

[14]  C. Sirlin,et al.  Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  M. Alessi,et al.  Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss , 2014, International Journal of Obesity.

[16]  Yoo-Seok Yoon,et al.  Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. , 2014, Radiology.

[17]  A. Tahrani,et al.  SGLT inhibitors in management of diabetes. , 2013, The lancet. Diabetes & endocrinology.

[18]  Lawrence A Leiter,et al.  Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial , 2013, The Lancet.

[19]  S. Seino,et al.  Insulin secretion and computed tomography values of the pancreas in the early stage of the development of diabetes , 2012, Journal of diabetes investigation.

[20]  F. Schick,et al.  Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study , 2010, Diabetes/metabolism research and reviews.

[21]  F. Schick,et al.  Quantification of Pancreatic Lipomatosis and Liver Steatosis by MRI: Comparison of In/Opposed-Phase and Spectral-Spatial Excitation Techniques , 2008, Investigative radiology.

[22]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[23]  W. Kiess,et al.  Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. , 2005, Best practice & research. Clinical endocrinology & metabolism.

[24]  A. Shapiro,et al.  Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. , 2004, Diabetes.

[25]  Victor Couture,et al.  Appendix for online publication , 2007 .

[26]  James Xiao,et al.  Supporting Information , 2005 .